BioHale® Trehalose Dihydrate is suitable for use in a wide variety administration routes including parenteral, inhalation and ophthalmic. In particular, it is commonly used for the lyoprotection and cryoprotection of therapeutic proteins, especially for parenteral administration.
Other applications include use as stabilizing agent during the freeze–thaw and lyophilization of liposomes; and for stabilization of blood cells as well as monoclonal antibodies. Beyond our excipient portfolio, customers benefit from our technical solutions and regulatory support to unlock their competitive advantage.
Our BioHale® excipients comply with the global regulatory requirements of the pharmaceutical industry (Ph. Eur., USP-NF, JP, ChP) and hold a Chinese Drug Master File (cDMF).
Download our product brochure here
If you would like to meet our Biopharma expert, please click here.
